Impact of SARS-CoV-2 on the clinical presentation of juvenile idiopathic inflammatory myopathies
Authors' conclusion
While our exploratory single-center study did not find significant differences in JIIM diagnosed pre- and post-pandemic
Study context
- Population
- Patients diagnosed with juvenile IIM (JIIM) before age 19 at The Children's Hospital at Montefiore
- Participants
- 51 patients
- Exposure
- JIIM diagnosed post-COVID-19 vs pre-COVID-19
- Post-COVID-19n = 13
- Outcome
- JIIM clinical presentation, post- vs pre-pandemic
Methodological detailssingle-centre, exploratory
- Single-centre
- Exploratory
Main finding
As reported in the abstract
- Post-pandemic patients tended to be older, female, and have non-specific cutaneous manifestations (not statistically significant)
- Fewer post-pandemic patients had delays in JIIM diagnosis
Observational data: associations, not effects.
Further findings
- Known or suspected SARS-CoV-2 exposure among those with onset after January 1, 2020 — Post-COVID-19
- 60%
- Post-COVID-19 patients with JIIM symptom onset after January 1, 2020
- 77% · 10 of 13
Original publication
Impact of SARS-CoV-2 on the clinical presentation of juvenile idiopathic inflammatory myopathies. Pediatr Rheumatol Online J. Published 11 August 2023. doi:10.
Composed by AI from the published abstract and checked against it. How Briefs are made →